(Q34243582)

English

Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry (English)

1 reference

Europe PubMed Central

31 July 2017

computed tomography

1 reference

based on heuristic

inferred from title

Robert A Stockley

1

object named as

Robert A Stockley

1 reference

Europe PubMed Central

31 July 2017

author name string

David G Parr

2

1 reference

Europe PubMed Central

31 July 2017

Eeva Piitulainen

3

1 reference

Europe PubMed Central

31 July 2017

Jan Stolk

4

1 reference

Europe PubMed Central

31 July 2017

Berend C Stoel

5

1 reference

Europe PubMed Central

31 July 2017

Asger Dirksen

6

1 reference

Europe PubMed Central

31 July 2017

publication date

5 October 2010

1 reference

Europe PubMed Central

31 July 2017

Respiratory Research

1 reference

Europe PubMed Central

31 July 2017

11

1 reference

Europe PubMed Central

31 July 2017

136

1 reference

Europe PubMed Central

31 July 2017

describes a project that uses

computed tomography

1 reference

based on heuristic

inferred from title

https://scigraph.springernature.com/pub.10.1186/1465-9921-11-136

0 references

Meta-analysis of individual participant data: rationale, conduct, and reporting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Scales to assess the quality of randomized controlled trials: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Predictors of mortality in alpha1-antitrypsin deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

6 July 2018

Small airways in severe panlobular emphysema: mural thickening and premature closure.

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-136

21 January 2018

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-136

21 January 2018

Rate of progression of lung function impairment in alpha1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-136

21 January 2018

Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment.

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-136

21 January 2018

Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-136

21 January 2018

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-136

21 January 2018

Radiologic and clinical features of COPD patients with discordant pulmonary physiology: lessons from alpha1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-136

21 January 2018

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-11-136

21 January 2018

A clinical trial of efficacy of antiproteolytic therapy: can it be done?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2964614

28 October 2018

Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products

1 reference

https://pubmed.ncbi.nlm.nih.gov/20920370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20920370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20920370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the economic challenges posed by orphan drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20920370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exercise capacity predicts health status in alpha(1)-antitrypsin deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/20920370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health status

1 reference

https://pubmed.ncbi.nlm.nih.gov/20920370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1465-9921-11-136

1 reference

Europe PubMed Central

31 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34243582&oldid=1954310444"